← All trials
NCT02922686
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2016
- Primary completion
- Dec 1, 2019
- Completion date
- Dec 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 414
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Royal College of Surgeons, IrelandLead sponsor
- Mater Misericordiae University HospitalOverall official - principal investigator
- National University of IrelandOverall official - principal investigator
- Health Research Board, IrelandCollaborator
- Royal College of Surgeons, IrelandOverall official - principal investigator
- Mercy UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.